NCT00362557

Brief Summary

Any patient already receiving a scheduled MR scan of the body for any clinical indication will be eligible for this program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2001

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2001

Completed
4.9 years until next milestone

First Submitted

Initial submission to the registry

August 9, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 10, 2006

Completed
9.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

September 23, 2019

Status Verified

September 1, 2019

Enrollment Period

14.3 years

First QC Date

August 9, 2006

Last Update Submit

September 19, 2019

Conditions

Clinically Indicated MR Imaging

Outcome Measures

Primary Outcomes (1)

  • Magnetic resonance signal

    Magnetic resonance imaging acquires signal from the human body. The signal will be measured at the time of the patient study. The amount of signal change will be measured between subjects.

    One Hour

Interventions

MRIDEVICE

Magnetic resonance imaging

Eligibility Criteria

AgeUp to 100 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals who may require a body MRI examination

You may qualify if:

  • Male or Female clinically scheduled to undergo MR Imaging at Johns Hopkins Medical Institutions

You may not qualify if:

  • Contraindications to MR Imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

Related Publications (1)

  • Pontiff M, Moreau NG. Safety and Feasibility of 1-Repetition Maximum (1-RM) Testing in Children and Adolescents With Bilateral Spastic Cerebral Palsy. Pediatr Phys Ther. 2022 Oct 1;34(4):472-478. doi: 10.1097/PEP.0000000000000941. Epub 2022 Aug 12.

    PMID: 35960137DERIVED

Study Officials

  • David A Bluemke, MD PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2006

First Posted

August 10, 2006

Study Start

September 1, 2001

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

September 23, 2019

Record last verified: 2019-09

Locations

US(1)